Clinical Trials in Chicago

Showing 10041-10060 of 20,493 trials

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

NCT03227029

The purpose of this study was to evaluate the infectivity, safety, and immunogenicity of the recombinant live-attenuated respiratory syncytial virus (RSV) vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 when delivered as nose drops to RSV-seronegative infants 6 to 24 months of age. This study was a companion study to Center for Immunization Research (CIR) 321.

Respiratory Syncytial Virus Infections

National Institute of Allergy and Infectious Diseases (NIAID)65 participantsStarted Sep 2017

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +9 more locations

COMPLETEDPhase 42.2 miles

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

NCT02519777

People infected with HIV often have cognitive dysfunction even if they are on antiretroviral therapy (ART) and have undetectable viral loads. The study evaluated if the addition of maraviroc (MVC) and dolutegravir (DTG) (which are two antiretroviral \[ARV\] medications) to participants' existing ART regimens improved participants' neurocognitive performance.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)191 participantsStarted Apr 2016

Los Angeles, California, United States • San Diego, California, United States • Torrance, California, United States +27 more locations

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

Find Trials by Condition in Chicago

Genetic Analysis of Pediatric Psoriasis

Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome

CMP vs Fascia Iliaca Block

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)

Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer

A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis

Reconnecting: Improving Interoception to Reduce Suicidal Ideation in the Military

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors

Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease

A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

Immunogenicity and Safety of a Purified Vero Rabies Vaccine

Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.